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Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of 1 adverse effects or any other drug related problems. Recently its concerns have been grown to include herbals, traditional and complementary medicines, blood products, biological or medical devices and vaccines. Pharmacovigilance 2 is not new to India and has in fact been going on since 1998 when India decided to join the Uppsala Centre for adverse event monitoring. ADRs are important causes of morbidity and mortality all over the world. They account for 3, 4 approximately 10-20% of all hospitalized patients.
The overall incidence of serious ADRs is 6.7% and that of fatal is 5 0.32%. It has been estimated that every year around 1,06,000 people die in USA because of ADRs which makes these reactions fourth leading cause of death after heart 6 diseases, cancer and stroke. The estimated cost of mortality and morbidity related to ADRs in USA is more than $75 7 billion annually. In 1893, the Lancet formed a commission that invited doctors in Britain and its colonies to report anesthesia related deaths. This was done after a 15 year Hannah Greener died after administration of chloroform, a 8 new anesthetic at that time. This reporting system thus formed the fore-runner of today's spontaneous reporting 9 system. The study was conducted to analyse the pattern of observed Adverse Drug Reactions using World Health Organisation-Uppsala Monitoring Center (WHO-UMC) Causality Assessment Algorithm in medicine ward of All India Institute of Medical Sciences (AIIMS). st A Prospective study was carried out from 1 March 2013 to th 30 December 2013. The total number of patients were 300. Before enrolling the patients, they were provided with patient's information sheet and the informed consent was taken. All the 300 admitted patients were observed daily whether they developed any of adverse events (AE) or not. If any AE was identified, it was written down in Central Drugs Standard Control Organization (CDSCO) ADR reporting format. The association was observed between the drug and adverse events using WHO-UMC causality assessment scale. Data obtained were entered in Microsoft Excel and analysed by SPSS. The research was approved from AIIMS Institutional Ethics Committee.
Among the 300 patients enrolled in the study 41 patients (13.66%) developed 59 ADRs. Among the 59 ADRs, 31 were observed in males (52.54%) and 28 in females (47.46%). The mean age of study participants among the male was 42.36 There was no significant difference of ADRs in males and females (p =0.194) as shown in (Table 1) . Among the observed 59 ADRs in 41 patients, majority developed only one ADR. The major ADR was diarrhea followed by gastritis and depressed level of consciousness (sedation). The detailed has been given in Table 2 . Among the patients observed with ADRs, the most common primary diseases for admission were tuberculosis and infections (Table 3) . Antimicrobials (42.37%) were found to be most commonly used drugs that caused ADRs followed by drugs used to treat central nervous system disorders, immunosuppressant drugs and respiratory drugs respectively ( It was observed that out of 59 ADRs, 57 were possible and 2 were probable. This suggests that most of the ADRs categorized as 'possible' had negative re-challenge, the patient recovered within a plausible length of time following withdrawal of the drug. No other causality assessment category was observed (Table 5 ).
Table-1 : Distribution of ADRs on the basis of gender
ADRs
DISCUSSION
One of the major cause of morbidity and mortality all over the world is adverse drug reaction. The incidence of ADRs in 10 hospital varies from 10-20%. According to FDA drug review, overall 51% of approved drugs have serious adverse effects 11 that could not be detected prior to their approval. In a study 12 by Sjoquist F, 30-50 % of these ADRs could have been prevented since they were dose dependent. However, studies conducted are few and the reported incidence of 13 ADRs varies greatly. Arulmani antimicrobials. To strengthen and further emphasize the validity of our findings, we carried out causality assessment using WHO-UMC's scale where most of the ADRs were possible and few were probable.
Incidence of adverse drug reactions in the present study was within the reported range mentioned in the literature. All the ADRs were nontoxic reactions and the gastrointestinal disorder was the most common ADR. The safety assessment should be considered as an integral part of everyday clinical practice. There are new drugs being launched in the market and to ensure safe use of drugs, there is a need of pharmacovigilance.
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